Page last updated: 2024-11-04

sulfamethoxazole and Chagas Disease

sulfamethoxazole has been researched along with Chagas Disease in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ang, CW1
Lee, BM1
Jackson, CJ1
Wang, Y1
Franzblau, SG1
Francisco, AF1
Kelly, JM1
Bernhardt, PV1
Tan, L1
West, NP1
Sykes, ML1
Hinton, AO1
Bolisetti, R1
Avery, VM1
Cooper, MA1
Blaskovich, MAT1

Other Studies

1 other study available for sulfamethoxazole and Chagas Disease

ArticleYear
Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection.
    Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

    Topics: Animals; Chagas Disease; Disease Models, Animal; Mice; Mycobacterium tuberculosis; Nitroimidazoles;

2022